These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 22835262

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF, de Jong MC, Kloosterhuis GJ, Zuiderveen J, Jonkman MF, Pas HH.
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [Abstract] [Full Text] [Related]

  • 5. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering.
    Yoshida K, Ishii K, Shimizu A, Yokouchi M, Amagai M, Shiraishi K, Shirakata Y, Stanley JR, Ishiko A.
    J Dermatol Sci; 2017 Mar; 85(3):197-207. PubMed ID: 28024684
    [Abstract] [Full Text] [Related]

  • 6. Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.
    Ohata C, Ishii N, Furumura M.
    J Cutan Pathol; 2014 Nov; 41(11):880-9. PubMed ID: 25265985
    [Abstract] [Full Text] [Related]

  • 7. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T, Fujii Y, Ishida A, Handa M, Tanikawa A, Amagai M, Nishikawa T.
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
    Cirillo N, Gombos F, Lanza A.
    J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus.
    Cirillo N, Santoro R, Lanza M, Annese P, Gombos F, Lanza A.
    Clin Exp Dermatol; 2008 Jan; 33(1):32-5. PubMed ID: 17983457
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A, Koga H, Suárez-Fernández R, Ohata C, Ishii N, Irarrazaval I, Teye K, Ohyama B, Hashimoto T.
    Eur J Dermatol; 2014 Jan; 24(2):174-9. PubMed ID: 24776707
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Two cases of cutaneous-type pemphigus vulgaris and a case of pemphigus foliaceus without mucosal involvement despite high anti-desmoglein 3 autoantibody levels.
    Terada A, Akasaka E, Nakano H, Sawamura D.
    J Dermatol; 2023 Nov; 50(11):1501-1505. PubMed ID: 37485682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.